Clinical significance and long term evolution of mesangial proliferative IgM nephropathy among Jordanian children

Annals of Saudi Medicine

Volumn 23, Issue 5, 2003, Pages 323-327

  Hamed, Radi M A ^a,b  

^a JORDAN UNIVERSITY HOSPITAL   (Jordan)

^b NONE   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FIBRINOGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISOLONE; SERUM ALBUMIN; STEROID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; JORDAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LONG TERM CARE; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; REMISSION; RISK BENEFIT ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0141925760     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2003.323     Document Type: Article

References (33)

1. Donia, AF, Sobh MA, Mostafa FE, Bakr, MA, Foda MA. Clinical significance and long-term evolution of minimal change histopathologic variants and IgM nephropathy among Egyptians. J Nephrol 2000; 13 (4):275-281.
2. Pardo V, Reisgo I, Zilleruelo G, Strauss J. The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome. Am J Kidney Dis. 1984; 3(4):264-269.
3. Vilches AR, Turner DR, Cameron JS, Ogg CS, Chantler C, Williams DG. Significance of mesangial IgM deposits in "minimal change" nephrotic syndrome. Lab Invest. 1982; 46(1):10-15.
4. Al-Eisa A, Carter JE, Lirenman DS, Magil AB. Childhood IgM nephropathy: Comparison with minimal change disease. Nephron. 1996; 72(1):37-43.
5. Garcia del Moral R, Gomez-Morales M, Cortes V, Aguayo ML, Gigososo RL, Lardelli P, Navas A, Aneiros J, Aguilar D. Mononuclear cell subsets in IgM mesangial proliferative glomerulonephritis. A comparative study with minimal change nephrotic syndrome and immunonegative mesangial proliferative glomerulonephritis. Nephron. 1993; 65(2):215-221.
6. Chen WP, Lin CY. Augmented expression of interleukin-6 and interleukin-1 in the mesangium of IgM mesangial nephropathy. Nephron. 1994; 68(1):10-19.
7. Scolari R, Scaini P, Savoldi S, Parti E, Sacchi G, Amoroso A, Mazzola G, Canale L, Borelli I, Cristinelli L, Sandrini S, Setti G, Maiorca R. Familial IgM mesangial nephropathy-a morphologic and immunogenetic study of three pedigrees. Am J Nephrol. 1990;10 (4):261-268.
8. Glassock RL, Cohen AH, Benett CM, Martines-Maldonado M. Primary glomerular disease. In Brenner BM, and Rector FC eds: The Kidney. 2nd ed. W.B.Saunders: Philadelphia; 1981:1315.
9. Cohen AH, and border WA: Mesangial proliferative glomerulonephritis. Sem Nephrol. 1982; 2:228.
10. Glassock RJ. The nephritic syndrome. Hosp Pract. 1979;14:105.
11. Heptinstall RH. Pathology of the Kidney. 3rd ed. Boston:Little Brown & Co.; 1983:637.
12. A Report of the International Study of Kidney Disease in Children: Nephrotic syndrome in children. Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int. 1978;13:159.
13. Habib R, Churg J, Bernstein J, Cameron JS, Cohen AH, Gagnadoux M-F, and Lewis EJ. Minimal change disease, mesangial proliferative glomerulonephritis and focal sclerosis: individual entities or a spectrum of disease? In Robinson RR eds. Nephrology. New York: Springer-Verlag; 1984: 634.
14. Waldherr R, Gubler MC, Levy M, and Habib R: The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol. 1978;10-171.
15. Brown EA, Upadhayaya K, Hayslett JP, Kashgarian M, Siegle NJ. The clinical clourse of mesangial proliferative glomerulonephritis. Medicine. 1979; 58:295.
16. Murphy WM, Jukkola AF, and Roy S. Nephrotic syndrome with mesangial-cell proliferation in children - A distinct entity. Am J Clin Path. 1979;72:27.
17. Churg J, Habib R, and White RH. Pathology of nephrotic syndrome in children. Lancet. 1970;1:1299.
18. Cohen AH, Border WA, Glassock RJ. Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest. 1978; 38:610-619.
19. Esperza A, Bhasin H, Nayak R, Abuelo G, Garella S. IgM deposits in mesangial proliferative glomerulonephritis (MSPGN). Kidney Int. 1976;10:542.
20. Cavallo T, Johnson MP. Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits. Nephron. 1981; 27:281-284.
21. Tejani A, Nicastri AD. Mesangial IgM nephropathy. Nephron. 1983; 35:1-5.
22. Ji-Yun Y, Tyrone M, Siblet R, Michael AF. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Kidney Int. 1984; 25:100-106.
23. Murphy MJ, Bailey RR, McGiven AR. Is there an IgM nephropathy? Aust N Z J Med. 1983; 13:35-38.
24. Hamed R. Childhood renal disorders in Jordan. J Nephrol. 1995;8:162-166.
25. Hamed R. Treatment of idiopathic nephrotic syndrome with Cyclosporin A in children. J Nephrol. 1997;10:266-270.
26. Lawler W, Williams G, Tarpey P, Mallick NP. IgM associated primary diffuse mesangial proliferative glomerulonephritis. J Clin Pathol. 1980;33:1029-1031.
27. Allen WR, Travis LB, Cavallo T, Brouhard BH, Cunningham RJ. Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: Clinical relevance. J Pediatr. 1982; 100:188-191.
28. Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR. Cyclosporin-induced remission of relapsing nephrotic syndrome in children. J Paediatr. 1987;111:1056-1062.
29. Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F, Pasqualli S, Castellani A, Della Casa-Alberighi O. A randomized trial of Cyclosporin in steroid-resistant idiopathic nephrotic syndrome. Kidney Int. 1993;43:1377-1384.
30. Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR. Cyclosporin A induced remission of relapsing nephrotic syndrome in children. Kidney Int. 1988;33:729-734.
31. Niaudet P, Broyer M, Habib R. Treatment of idiopathic nephrotic syndrome with Cyclosporin A in children. Clin Nephrol. 1991; S31-S36.
32. Cohen AH, Border WA, Glassock RJ. Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest. 1977; 36:334-335.
33. Habib R, Niaudet P. Comparison between pre- and posttreatment renal biopsies in children receiving Ciclosporin for idiopathic nephrosis. Clin Nephrol. 1994; 42:141-146.